Oral Candida spp. Density as a Blood Glucose Marker in Diabetes Mellitus Patients
DOI:
https://doi.org/10.35916/thmr.v7i2.133Keywords:
Blood glucose, Candida spp., colony density, diabetes mellitus, oral candidiasis, salivaryAbstract
Candida spp. is a commensal fungus in the oral cavity that can become an opportunistic pathogen when there is a decrease in the immune system or metabolic disorders such as diabetes mellitus. Hyperglycemia in people with diabetes increases salivary glucose levels, which can be a nutrient source for Candida, thus triggering increased density, biofilm formation, and antifungal resistance. This study aims to analyse the relationship between blood glucose levels and oral Candida spp. density in patients with diabetes mellitus. The study used a cross-sectional design in 29 Guntung Manggis Banjarbaru Community Health Centre patients. Saliva samples were collected by mouthwash and planted on Hichrome Candida Differential Agar (HCDA) media to calculate colony density. At the same time, blood glucose levels were measured spectrophotometrically using the GOD-PAP method. The results showed abnormal blood glucose levels (?200 mg/dL) were found in 16 respondents (55.2%), and abnormal Candida spp. density (>500 CFU/mL) was also found in 16 respondents (55.2%). The growth of Candida spp. detected in 24 samples (82.8%). The Chi-square test showed a significant association between hyperglycemia and increased oral Candida spp. density (p = 0.017). These findings suggest that hyperglycemia plays a role in increased Candida density in the oral cavity. Hence, monitoring blood glucose levels and oral Candida density is important for preventing fungal infection complications in patients with diabetes mellitus.
References
Rodrigues CF, Henriques M. Candida spp. infections in patients with diabetes mellitus. J Clin Med. 2019;8(1):76.
Lopes JP, Lionakis MS. Pathogenesis and virulence of Candida albicans. Virulence. 2022;13(1):89-121.
Gomes CC, Guimaraes LS, Pinto LCC, Camargo GADCG, Valente MIB, Sarquis MIDM. Investigations of the prevalence and virulence of Candida albicans in periodontal and endodontic lesions in diabetic and normoglycemic patients. J Appl Oral Sci. 2017;25(3):274-81.
Mandal SM, Mahata D, Migliolo L, Parekh A, Addy PS, Mandal M, et al. Glucose directly promotes antifungal resistance in the fungal pathogen Candida spp. J Biol Chem. 2014;289(37):25469-73.
Moharram AM, Abdel-Galil FA, Hafez WMM. On the enzymes' actions of entomopathogenic fungi against certain indigenous and invasive insect pests. Egypt J Biol Pest Control. 2021;31:1-9.
Mohammed L, Jha G, Malasevskaia I, Goud HK, Hassan A. The interplay between glucose and yeast infections: Do diabetics have a greater predisposition to develop oral and vulvovaginal candidiasis? Cureus. 2021;13(2):e13443.
Mishra N, Trivedi A, Gajdhar SK, Bhagwat H, Khutwad GK, Mall PE, et al. Correlation of blood glucose levels, salivary glucose levels and oral colony forming units of Candida albicans in type 2 diabetes mellitus patients. J Contemp Dent Pract. 2019;20(4):494-8.
Hosida TY, Cavazana TP, Henriques M, Pessan JP, Delbem ACB, Monteiro DR. Interactions between Candida albicans and Candida glabrata in biofilms: influence of the strain type, culture medium and glucose supplementation. Mycoses. 2018;61(4):270-8.
Wijerathna AAWM, Weerasekera WBMCRD, Jayawardene KLTD, Ratnapreya S, Bandara HMHN. Oral prevalence of Candida in adolescents on removable orthodontic appliance therapy at Dental Teaching Hospital, Peradeniya, Sri Lanka – a pilot study. Ceylon J Sci. 2024;53(4):201-8.
HiMedia Laboratories. HiCrome™ Candida Differential Agar [Internet]. 2023 [cited 2025 May 7]. Available from: https://www.himedialabs.com/us/m1297a-hicrome-candida-differential-agar.html
American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: Standards of care in diabetes—2025. Diabetes Care. 2025;48(Suppl 1):S27-49.
Hamrun N, Mahardhika A. Jumlah koloni Candida albicans pada pemakai gigitiruan penuh berdasarkan lama pemakaian. Makassar Dent J. 2014;3(3):112-7.
Vaziri PB, Vahedi M, Mortazavi H, Abdollahzadeh SH, Hajilooi M. Evaluating salivary glucose, IgA and flow rate in diabetic patients: a case-control study. J Dent (Tehran). 2010;7(1):13-8.
Elkafri H, Mashlah A, Shaqifa A. Relationship between blood glucose levels and salivary pH and buffering capacity in type II diabetes patients. East Mediterr Health J. 2014;20(2):121-6.
Okuyama K, Yanamoto S. Saliva in balancing oral and systemic health, oral cancer, and beyond: a narrative review. Cancers (Basel). 2024;16(24):4276.
Chojnowska S, Baran T, Wili?ska I, Sienicka P, Cabaj-Wiater I, Kna? M. Human saliva as a diagnostic material. Adv Med Sci. 2018;63(1):185-91.
Hostetter MK. Handicaps to host defense: effects of hyperglycemia on C3 and Candida albicans. Diabetes. 1990;39(3):271-5.
Gupta S, Nayak MT, Sunitha JD, Dawar G, Sinha N, Rallan NS. Correlation of salivary glucose level with blood glucose level in diabetes mellitus. J Oral Maxillofac Pathol. 2017;21(3):334-9.
Pérez-Ros P, Navarro-Flores E, Julián-Rochina I, Martínez-Arnau FM, Cauli O. Changes in salivary amylase and glucose in diabetes: a scoping review. Diagnostics (Basel). 2021;11(3):453.
